247 related articles for article (PubMed ID: 28680991)
1. Emergence of azole-resistant
Katiraee F; Teifoori F; Soltani M
Curr Med Mycol; 2015 Sep; 1(3):11-16. PubMed ID: 28680991
[TBL] [Abstract][Full Text] [Related]
2. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints].
Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
7. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.
Kiraz N; Dag I; Oz Y; Yamac M; Kiremitci A; Kasifoglu N
J Microbiol Methods; 2010 Aug; 82(2):136-40. PubMed ID: 20493911
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
9. Distribution and antifungal susceptibility profile of oropharyngeal
Benson M; Turyamuhika L; Mwesigwa A; Nalumaga PP; Kabajulizi I; Njovu IK; Mwebesa E; Luggya T; Ocheng F; Kateete DP; Itabangi H; Mboowa G; Sande OJ; Achan B
Ther Adv Infect Dis; 2024; 11():20499361241255261. PubMed ID: 38812710
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility pattern of
Badiee P; Badali H; Diba K; Ghadimi Moghadam A; Hosseininasab A; Jafarian H; Mohammadi R; Mirhendi H; Najafzadeh MJ; Shamsizadeh A; Soltani J
Curr Med Mycol; 2016 Mar; 2(1):24-29. PubMed ID: 28681009
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
12. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
13. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
14. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
[TBL] [Abstract][Full Text] [Related]
17. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of asymptomatic nosocomial candiduria due to
Aghili SR; Abastabar M; Soleimani A; Haghani I; Azizi S
Curr Med Mycol; 2020 Dec; 6(4):1-8. PubMed ID: 34195453
[TBL] [Abstract][Full Text] [Related]
19. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.
Hamza OJ; Matee MI; Moshi MJ; Simon EN; Mugusi F; Mikx FH; Helderman WH; Rijs AJ; van der Ven AJ; Verweij PE
BMC Microbiol; 2008 Aug; 8():135. PubMed ID: 18694525
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis.
Tamai IA; Pakbin B; Fasaei BN
BMC Res Notes; 2021 Mar; 14(1):93. PubMed ID: 33691787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]